Figure 3From: A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study Analysis of the recurrence-free probability in the subgroups defined according to Chi2 molecular signatures. A Kaplan-Meier analysis was performed on tumours of the training and validation sets that were correctly classified in the indicated molecular subgroups. The p value was calculated by using the log-rank test.Back to article page